BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp® (NYSE: LH), a leading global life sciences company, today announced a new collaboration with HealthVerity, Inc., the ...

Laboratory Corporation of America Holdings or LabCorp LH continues to remain in the headlines with major back-to-back developments within the company’s business. Following last week’s announcement of ...

Innovative collaboration advances the development of novel gene therapies for patients by providing coordinated services across Forge’s leading AAV manufacturing capabilities and Labcorp’s scientific ...

The yet-to-be-named new company will be publicly traded. Separating the laboratory testing work of LabCorp from the clinical trial services business, much of which came from acquisitions, will enable ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that Thomas (Tom) Pike will join Labcorp as president and chief executive officer of its ...

April 25 (Reuters) - Laboratory Corp of America Holdings (LH.N), opens new tab missed estimates for quarterly profit on Tuesday, as its drug development unit struggled against curbs on animal imports, ...

BURLINGTON – Labcorp on Thursday reported a third-quarter profit of $352.8 million yet its overall financials didn’t meet Wall Street expectations. But CEO Adam Schechter said the company “made ...

Laboratory Corp. of America Holdings LH2.47%increase; green up pointing triangle plans to spin off its unit focused on clinical drug trials, a move that will create a new stand-alone company in the ...

The positions in the table below reflect the Labcorp Drug Development's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to ...